NMS-P937
NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.
Product Specifications
CAS Number
1034616-18-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.52
Molecular Formula
C24H27F3N8O3
Notes
Research use only, not for human use.
Receptor
PLK1| PLK2| PLK3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7009121-01 0.02 mg
Recombinant Bacteroides fragilis ATP synthase subunit c (atpE)
Sign In for Pricing
View Details MBS7009121-02 0.1 mg
Recombinant Bacteroides fragilis ATP synthase subunit c (atpE)
Sign In for Pricing
View Details MBS7009121-03 5x 0.1 mg
Recombinant Bacteroides fragilis ATP synthase subunit c (atpE)
Sign In for Pricing
View Details 
836423 1 Pack (1 Panel (s) x 1 Pack)
E/A315//E001/NT-SA-PHOLUMB-300x150/1-B Facility & Office Signs & Labels (Adhesive)
Sign In for Pricing
View Details 125381-ML650 100 µL
CRYZ (Quinone Oxidoreductase, NADPH:Quinone Reductase, Zeta-crystallin) (MaxLight 650)
Sign In for Pricing
View Details